Key points from article :
Inbrain Neuroelectronics developed a graphene-based brain implant, and is gearing up for its first-in-human test.
This brain-computer interface (BCI) can record and stimulate the brain.
Graphene overcomes limitations of effectiveness from metal chips used in BCIs by avoiding Faradaic reactions.
The first human trial will be for brain tumor surgery at the University of Manchester.
The chip will help surgeons distinguish tumors from healthy tissue during surgery.
Inbrain's BCI also has applications for Parkinson's disease treatment.
The chip can decode brain signals to assess how well medications are working.
This may allow for reduced medication use and more targeted treatment for Parkinson's.
